跳至主要内容
临床试验/NCT06571669
NCT06571669招募中不适用

BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of IBD.

Boomerang Medical30 个研究点 分布在 1 个国家目标入组 137 人开始时间: 2025年1月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
137
试验地点
30
主要终点
Bowel Urgency

研究概览

简要总结

Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends mild signals to a nerve near the tailbone. It is placed during a same-day procedure.

详细描述

The main goal is to find out if bowel urgency gets better after 12 weeks, using a standard rating scale for bowel urgency. Adults ages 18 to 85 with ulcerative colitis may be able to join. Everyone in the study gets the device. There is no placebo group. Study visits continue for 12 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female
  • 18 to 85 years of age
  • Diagnosed with ulcerative colitis
  • Ability and willingness to consent to participate by signing the informed consent form
  • Ability to comply with the protocol and willingness to comply with all follow up requirements

排除标准

  • Any significant medical condition that is likely to interfere with study procedures, device operation, or likely to confound the results of the study
  • Any psychiatric or personality disorder at the discretion of the study investigator
  • Any active bacterial infection with a risk of bacteremia or sepsis (e.g. presence of abscess)
  • Active clostridium difficile infection of the colon
  • Active cytomegalovirus (CMV) infection of the colon
  • Evidence of colonic perforation
  • Fulminant colitis requiring emergency surgery
  • Microscopic, ischemic or infectious colitis
  • Unresected neoplasia of the colon
  • Colonic stricture unable to pass a colonoscope
  • Current evidence of cancer in the gastrointestinal tract
  • Current participation in another clinical trial
  • Previous history of surgery for ulcerative colitis, or probably to require such intervention
  • Previously implanted with a neurostimulation device or participated in a neurostimulation trial
  • Inability to operate the patient programmer

研究组 & 干预措施

Treatment Arm

Experimental

Patients implanted with neuromodulation

干预措施: Neuromodulation (Device)

结局指标

主要结局

Bowel Urgency

时间窗: 12 weeks

Bowel urgency at 12 weeks using the urgency numeric rating scale (URNS). The Urgency NRS is a patient-reported outcome (PRO) that quantifies the severity of bowel urgency on a scale from 0 to 10, where 0 equals no bowel urgency and 10 equals worst possible urgency.

次要结局

未报告次要终点

研究者

发起方
Boomerang Medical
申办方类型
Industry
责任方
Sponsor

研究点 (30)

Loading locations...

相似试验

相关资讯